Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $23.31 USD
Change Today +0.28 / 1.22%
Volume 681.1K
HALO On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 08/4/15 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - halozyme therapeutics inc (HALO)

NameBoard RelationshipsTitleAge
Helen I. Torley M.B. Ch. B., M.R.C.P.30 RelationshipsChief Executive Officer, President and Director52
Laurie Stelzer No RelationshipsChief Financial Officer--
William J. Fallon No RelationshipsVice President of Manufacturing and Operations58
Athena Countouriotis M.D.No RelationshipsChief Medical Officer43
Harry J. Leonhardt Esq.No RelationshipsChief Compliance Officer, Senior Vice President , General Counsel and Corporate Secretary58

Board Members - halozyme therapeutics inc (HALO)

NameBoard RelationshipsPrimary CompanyAge
Kathryn E. Falberg 61 RelationshipsHalozyme Therapeutics, Inc.54
Helen I. Torley M.B. Ch. B., M.R.C.P.30 RelationshipsHalozyme Therapeutics, Inc.52
Gregory I. Frost Ph.D.15 RelationshipsIntrexon Corporation43
Connie L. Matsui 57 RelationshipsHalozyme Therapeutics, Inc.61
Thomas S. Edgington M.D.19 RelationshipsADViSYS, Inc.--

Executive Committees* - halozyme therapeutics inc (HALO)

Committee NameChairpersonBoard RelationshipsMembers
Audit CommitteeKathryn E. Falberg 61 Relationships3 Executives
Compensation CommitteeConnie L. Matsui 57 Relationships2 Executives
Nominating CommitteeConnie L. Matsui 57 Relationships3 Executives
Corporate Governance CommitteeConnie L. Matsui 57 Relationships3 Executives
Advisory BoardGregory I. Frost Ph.D. 15 Relationships8 Executives
View HALO Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HALO:US $23.31 USD +0.28

HALO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Amphastar Pharmaceuticals Inc $16.09 USD -0.14
Valeant Pharmaceuticals International Inc C$342.45 CAD +6.84
View Industry Companies
 

Industry Analysis

HALO

Industry Average

Valuation HALO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 35.6x
Price/Book 77.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 34.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HALOZYME THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.